2025 · 3rd Quarter (July 1 - Sep 30)

EDWARDS LIFESCIENCES LLC

Filed by EDWARDS LIFESCIENCES, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2025
Income: Not reported
Expenses: $280,000.00
Registrant: EDWARDS LIFESCIENCES, LLC
Client: EDWARDS LIFESCIENCES LLC
Filing UUID: 242f6bc8-90c0-427f-b179-3f412cd73f1e
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TAX · Taxation/Internal Revenue Code

Corporate Tax Reform Proposals

TRD · Trade (domestic/foreign)

Tariffs Japan Reimbursement of Medical Devices

HCR · Health Issues

Ensuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization/FDA User Fees Diversity in Clinical Trials

Literal federal measure citations: H.R. 5343, S.1717

MMM · Medicare/Medicaid

CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development

Literal federal measure citations: H.R. 5343, S.1717

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.